KeyMed Biosciences Inc
HKEX:2162
Intrinsic Value
The intrinsic value of one KeyMed Biosciences Inc stock under the Base Case scenario is 78.8 HKD. Compared to the current market price of 45.8 HKD, KeyMed Biosciences Inc is Undervalued by 42%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
KeyMed Biosciences Inc
Loading...
Fundamental Analysis

Revenue & Expenses Breakdown
KeyMed Biosciences Inc
Balance Sheet Decomposition
KeyMed Biosciences Inc
Current Assets | 2.5B |
Cash & Short-Term Investments | 2.2B |
Receivables | 69.5m |
Other Current Assets | 240.9m |
Non-Current Assets | 1.3B |
Long-Term Investments | 210m |
PP&E | 1.1B |
Intangibles | 9.7m |
Other Non-Current Assets | 5.4m |
Free Cash Flow Analysis
KeyMed Biosciences Inc
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
KeyMed Biosciences Inc
Revenue
|
428.1m
CNY
|
Cost of Revenue
|
-12.2m
CNY
|
Gross Profit
|
415.9m
CNY
|
Operating Expenses
|
-1B
CNY
|
Operating Income
|
-591.5m
CNY
|
Other Expenses
|
76.2m
CNY
|
Net Income
|
-515.2m
CNY
|
Profitability Score
Profitability Due Diligence
KeyMed Biosciences Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
Score
KeyMed Biosciences Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
KeyMed Biosciences Inc's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Score
KeyMed Biosciences Inc's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
KeyMed Biosciences Inc
According to Wall Street analysts, the average 1-year price target for KeyMed Biosciences Inc is 61.17 HKD with a low forecast of 55.55 HKD and a high forecast of 74.29 HKD.
Dividends
Current shareholder yield for KeyMed Biosciences Inc is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one KeyMed Biosciences Inc stock under the Base Case scenario is 78.8 HKD.
Compared to the current market price of 45.8 HKD, KeyMed Biosciences Inc is Undervalued by 42%.